Tiziana Life Sciences Ltd
NASDAQ:TLSA
Cash Flow Statement
Cash Flow Statement
Tiziana Life Sciences Ltd
Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | ||
---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||
Net Income |
(10)
|
(10)
|
(28)
|
(41)
|
(27)
|
(14)
|
(15)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
2
|
3
|
17
|
18
|
4
|
(5)
|
(4)
|
|
Cash Taxes Paid |
(1)
|
(1)
|
0
|
(1)
|
(1)
|
(1)
|
(0)
|
|
Change in Working Capital |
1
|
(1)
|
(0)
|
4
|
1
|
(2)
|
(1)
|
|
Cash from Operating Activities |
(7)
N/A
|
(8)
-23%
|
(12)
-43%
|
(19)
-56%
|
(22)
-17%
|
(21)
+5%
|
(20)
+5%
|
|
Investing Cash Flow | ||||||||
Capital Expenditures |
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
|
Other Items |
0
|
0
|
0
|
0
|
0
|
(3)
|
(4)
|
|
Cash from Investing Activities |
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-15%
|
0
N/A
|
(3)
N/A
|
(4)
-20%
|
|
Financing Cash Flow | ||||||||
Net Issuance of Common Stock |
2
|
18
|
78
|
62
|
0
|
0
|
0
|
|
Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Other |
0
|
(1)
|
(4)
|
(3)
|
0
|
0
|
0
|
|
Cash from Financing Activities |
2
N/A
|
17
+908%
|
74
+335%
|
58
-21%
|
(0)
N/A
|
0
N/A
|
(0)
N/A
|
|
Change in Cash | ||||||||
Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(0)
|
|
Net Change in Cash |
(5)
N/A
|
9
N/A
|
62
+618%
|
39
-36%
|
(24)
N/A
|
(26)
-10%
|
(24)
+7%
|
|
Free Cash Flow | ||||||||
Free Cash Flow |
(7)
N/A
|
(8)
-23%
|
(12)
-44%
|
(19)
-55%
|
(22)
-16%
|
(21)
+5%
|
(20)
+5%
|